0
Study focused on immune markers PD-1 and PD-L1 in TETs.
70 patients' tumor samples were analyzed.
PD-1 found mostly in immune cells, PD-L1 in tumor cells.
>80 percent of thymic carcinomas expressed high PD-L
1
High PD-L1 linked to advanced disease stages.
Need for further research on prognostic value of PD-L
2
Standardization of PD-L1 testing methods is recommended.
Newsletters
Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.
